Hydroxyurea remains effective long-term in reducing emergency department visits and hospital days for children living with ...

wiping out teams working on research about adults with cognitive disabilities and sickle cell disease. Work likely to be halted by the cuts includes the collection of data for studying Americans ...

Feb. 25, 2025 — A bone marrow transplant process is safe and curative for adults with sickle cell disease, according to results of a trial completed at about 20 cancer ... Brains of People With ...

Ten (10) patients with sickle cell disease will be treated with VAS-101 twice per week over 4 weeks for a total of 8 ...

Pfizer has announced the voluntary withdrawal of all lots of OXBRYTA (voxelotor) approved for treating sickle cell disease (SCD ... which called for additional assessment. The company has informed ...

NASHVILLE, Tenn. (WTVF) — One of Vanderbilt's latest studies has found a cure for sickle cell disease. Sickle cell is a blood disorder where the body creates mutated red blood cell proteins.

At Fred Hutch Cancer Center, we care for adults with sickle cell disease. Along with our local patients, we see many people from farther away, like Alaska. They get most of their care near home, but ...

Pfizer is voluntarily withdrawing its sickle cell disease (SCD) therapy Oxbryta ... crises and fatal events which require further assessment," and the company has pulled the drug from the market ...

Kamala Hospital and Research Centre for Thalassemia and Sickle Cell Disease, run by TSCS was designated as key Thalassaemia International Federation (TIF) Collaborating Centres in India ...

Vertex Pharma's £1.65 million ($2.05 million) gene-editing therapy for sickle cell disease (SCD), Casgevy ... according to the health technology assessment (HTA) agency. It is estimated that ...